Nuwellis宣布临时CEO接任 董事长Erb重掌公司帅印
公司董事会主席John Erb已接任临时总裁兼CEO职务。Erb在这一职位上拥有丰富经验，他曾于2015年11月至2021年1月期间担任Nuwellis的总裁兼CEO。他与公司的渊源可追溯至2012年9月成为董事，并于同年10月担任董事长。根据InvestingPro分析，尽管公司当前比率保持在2.03的稳健水平，但现金消耗速度较快，此时的领导层交接显得尤为关键。
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
(Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that Nestor Jaramillo, Jr. retired as President and Chief Executive ...
Nuwellis CEO Nestor Jaramillo retires, John Erb named interim CEO
Nuwellis (NUWE) announced that Nestor Jaramillo retired as president and CEO and as a director of the company, effective February 18. John Erb, ...
来自MSN21 小时
Nuwellis Appoints John Erb as Interim CEO
An announcement from Nuwellis ( ($NUWE) ) is now available. On February 24, 2025, Nuwellis, Inc. announced the retirement of Nestor Jaramillo, Jr.
阿思達克財經網2 年
美股异动丨Nuwellis盘前涨近11% 股价重新达到维持纳斯达克上市要求
12月29日丨Nuwellis盘前涨近11%，报10.16美元。Nuwellis周二表示，公司股份的收盘价至少连续10个交易日在1美元之上，已收到纳斯达克可以继续在市场交易 ...
Yahoo Finance3 个月
Nuwellis, Inc. (NUWE)
18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it ...
Nasdaq5 天
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow ...
Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...
Benzinga.com4 个月
Nuwellis (NASDAQ:NUWE) Stock Quotes, Forecast and News Summary
The FDA and Nuwellis warn of potential risks linked to AquaFlexFlow UF 500 Plus blood circuits. A recall addresses issues like therapy termination and patient injury risks.
Nuwellis, Inc.: JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% reductio ...
CNN1 年
Nuwellis, Inc.
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which ...
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% ...
Yahoo Finance18 天
Nuwellis, Inc. (NUWE)
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, is pleased to announce its ...